PGP and intrahepatic cholangiocarcinoma: Enhanced expression of P-gp examined by ICC in the resistant cell line was the lowest after the addition of DOX at the therapeutic concentration (K2, 0.09 μM), which correlated with a significant decrease of ABCB1 gene expression.